Pharmaceutical

MOMA Therapeutics and Roche sign cancer drug discovery deal

MOMA Therapeutics and Roche have signed a strategic partnership and licensing agreement for discovering drug targets for cancer.

Jan 5, 2024 - 18:00
MOMA Therapeutics and Roche sign cancer drug discovery deal
MOMA Therapeutics and Roche have signed a strategic partnership and licensing agreement for discovering drug targets for cancer.
Read the original article

Tags:

Previous Article

Insilico teams up with Menarini for breast cancer KAT6 inhibitor

Next Article

AbbVie and Umoja to develop new CAR-T therapies for cancer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Stéphane Bancel, Bernie Sanders spar over what Moderna owes the federal government

Stéphane Bancel, Bernie Sanders spar over what Moderna ...

Mar 22, 2023

STAT+: Pharmalittle: Sanofi plans to spin off its consumer health biz; EMA says no evidence GLP-1 drugs linked to thyroid cancer

STAT+: Pharmalittle: Sanofi plans to spin off its consu...

Oct 28, 2023

Nouscom extends Series C round to $82m for cancer vaccine trials

Nouscom extends Series C round to $82m for cancer vacci...

Mar 22, 2024